Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Results available

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants

ClinicalTrials.gov ID: NCT06060977

Public ClinicalTrials.gov record NCT06060977. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 6:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants With 50% or Greater Scalp Hair Loss

Study identification

NCT ID
NCT06060977
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Inmagene LLC
Industry
Enrollment
29 participants

Conditions and interventions

Interventions

  • IMG-007 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 24, 2023
Primary completion
Jan 13, 2025
Completion
Jan 13, 2025
Last update posted
Feb 8, 2026

2023 – 2025

United States locations

U.S. sites
11
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
Northwest Arkansas Clinical Trials Center, PLLC/ Hull Dermatology P.A. Rogers Arkansas 72758
Torrance Clinical Research Institute Inc. Lomita California 90717
Alliance Clinical Research of Tampa Tampa Florida 33615
Dawes Fretzin Clinical Resarch Group, LLC Indianapolis Indiana 47906
Options Research Group West Lafayette Indiana 47906
Lahey Hospital & Medical Center Burlington Massachusetts 01803
Great Lakes Research Group Inc. Bay City Michigan 48706
Skin Cancer and Dermatology Institute Reno Nevada 89509
Skin Search of Rochester, Inc. Rochester New York 14623
Stride Clinical Research LLC Sugar Land Texas 77479
Dermatology Specialists of Spokane Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06060977, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 8, 2026 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06060977 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →